89bio Inc.

NASDAQ: ETNB · Real-Time Price · USD
9.22
0.12 (1.32%)
At close: Aug 15, 2025, 3:59 PM
9.23
0.05%
After-hours: Aug 15, 2025, 04:10 PM EDT

89bio Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
126.06M 316.16M 55.26M 52.43M
Short-Term Investments
313.89M 262.71M 132.91M 98.29M
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
640K 396K 289K 290K
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
n/a n/a n/a n/a
Total Current Assets
476.45M 593.53M 196.08M 161.98M
Property-Plant & Equipment
1.59M 2.34M 455K 150K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
2.23M 2.73M 744K 440K
Total Assets
478.69M 596.27M 196.82M 162.42M
Account Payables
15.38M 8.59M 12.5M 6.84M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a 168K 2.5M
Other Current Liabilities
6.87M 14.28M 7.61M 7.03M
Total Current Liabilities
36.13M 29.61M 24.61M 19.54M
Long-Term Debt
35.73M 24.8M 20.19M 16.9M
Other Long-Term Liabilities
4.95M 3.74M n/a 30K
Total Long-Term Liabilities
41.77M 30.35M 20.38M 16.93M
Total Liabilities
77.9M 59.96M 44.99M 36.47M
Total Debt
37.55M 27.11M 20.55M 19.4M
Common Stock
120K 93K 51K 20K
Retained Earnings
-824.51M -457.43M -315.24M -213.22M
Comprehensive Income
563K 190K -350K -64K
Shareholders Equity
400.79M 536.31M 151.83M 125.96M
Total Investments
313.89M 262.71M 132.91M 98.29M